Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group Study

PURPOSE: Intraperitoneal chemotherapy has shown a survival advantage over intravenous chemotherapy for women with newly diagnosed optimally debulked epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. However, significant toxicity has limited its acceptance. In an effort to reduce t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dizon, Don S., Sill, Michael W., Gould, Natalie, Rubin, Stephen C., Yamada, S. Diane, DeBernardo, Robert L., Mannel, Robert S., Eisenhauer, Eric L., Duska, Linda R., Fracasso, Paula M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3201726/
https://ncbi.nlm.nih.gov/pubmed/21820161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.07.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados